William McConnell

Bill McConnell has led The Deal 's coverage of the nation's capital since becoming Washington bureau chief in 2005. His reporting has covered a range of issues critical to the deal community -- antitrust, financial reform, corporate accounting, tax policy, the impact of national security concerns on dealmaking and the effect consolidation has had on American society. Prior to joining The Deal, Bill was the Washington correspondent for Broadcasting & Cable, where he spent seven years reporting on the debate over media ownership, the FCC's crackdown on broadcast indecency and the rollout of digital television.

Recent Articles By The Author

Western Digital Moves to Block Toshiba's Deal With Bain Group

Western Digital Moves to Block Toshiba's Deal With Bain Group

The latest move over the disputed memory chip unit is "troubling" to SanDisk's parent.

Walgreens to Begin Rite Aid Transformation in 'Carefully Planned Phases'

Walgreens to Begin Rite Aid Transformation in 'Carefully Planned Phases'

Store purchases by Walgreens are to begin next month and are expected to be completed in spring 2018.

Trump's Lattice Deal Block Could Cause Cascade of China Cancellations

Trump's Lattice Deal Block Could Cause Cascade of China Cancellations

President Donald Trump's decision to block Canyon Bridge Capital Partners LLP's $1.3 billion plan to acquire Lattice Semiconductor Corp. could trip a domino effect of dealmakers calling off pending transactions.

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Patent lawyers are intrigued and competitors will likely challenge, but the move to transfer ownership of the patent to the Saint Regis Mohawk tribe could cause other companies to try a similar tack.

FDA Approves First 'Biosimilar' for Cancer Treatment

FDA Approves First 'Biosimilar' for Cancer Treatment

Amgen sets to offer a competitor to Roche's Avastin.